help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, B.
Right arrow Articles by Kalra, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, B.
Right arrow Articles by Kalra, S. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Endocrinology Vol. 140, No. 6 2868-2875
Copyright © 1999 by The Endocrine Society


ARTICLES

Daily Changes in Hypothalamic Gene Expression of Neuropeptide Y, Galanin, Proopiomelanocortin, and Adipocyte Leptin Gene Expression and Secretion: Effects of Food Restriction1

B. Xu, P. S. Kalra, W. G. Farmerie and S. P. Kalra

Department of Neuroscience (B.X., S.P.K.), Department of Physiology (P.S.K.), Interdisciplinary Center for Biotechnology Research (W.G.F.), University of Florida College of Medicine, Gainesville, Florida 32610

Address all correspondence and requests for reprints to: Satya P. Kalra, Ph.D., University of Florida College of Medicine, Department of Neuroscience, 100 South Newell Drive Building 59, Box 100244, Gainesville, Florida 32610-0244. E-mail: skalra{at}ufbi.ufl.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The participation of hypothalamic neuropeptide Y (NPY)-, galanin (GAL)-, and opioid-producing neurons in the restraint on food intake exerted by adipocyte leptin has recently been recognized. To further understand the interplay between the central appetite-stimulating- and peripheral appetite-inhibiting signals in the management of daily food intake, we have examined the daily patterns in expression of the hypothalamic neuropeptides and leptin receptor (R) and adipocyte leptin gene expression and secretion in freely feeding (FF) rats. These analyses were extended to determine the impact of food restriction (FR) to 4 h daily for 4 weeks. Groups of FF and FR rats were killed at 4-h intervals during a 24-h period, and hypothalamic NPY, GAL, POMC, and leptin-R gene expression and leptin gene expression were evaluated by RNase protection assays and serum leptin and corticosterone (CORT) levels were estimated by RIA. The following new findings emerged: 1) In FF rats, hypothalamic NPY messenger RNA (mRNA) levels fluctuated during the course of 24 h with high levels at 0700 h and 1100 h followed by a decrease at 1500 h during the lights-on phase that was sustained throughout the dark phase (1900 h–0500 h) of the light-dark cycle. Hypothalamic GAL and POMC mRNA also displayed daily patterns but with a different time course; GAL and POMC gene expression were elevated 4 h later than NPY mRNA at 1100 h and 1500 h. 2) Although FR to 4 h between 1100 h and 1500 h resulted in maintenance of body weight compared with a steady weight gain in FF rats, the daily patterns of fluctuations in hypothalamic neuropeptide gene expression were abolished. 3) In FF rats, hypothalamic leptin-R and adipocyte leptin gene expression and serum leptin levels displayed a daily pattern temporally different from that of hypothalamic neuropeptide gene expression. Adipocyte leptin mRNA remained low during the lights-on phase but increased at the onset of the lights-off phase (1900 h) and remained elevated through the dark phase. 4) Hypothalamic leptin-R gene expression, like that of adipocyte leptin gene expression, rose abruptly at the onset of nocturnal feeding behavior but receded progressively to low range thereafter. 5) On the other hand, a dichotomy in the daily rise in adipocyte leptin gene expression and leptin secretion was observed in FF rats. Unlike adipocyte leptin mRNA, serum leptin increased at 2300 h, 4 h after initiation of ingestive behavior. 6) In FR rats, adipocyte leptin gene expression fluctuated little over the 24-h period but, as in FF rats, leptin hypersecretion peaked 4 h after initiation of food intake. 7) In both FF and FR rats, increased serum CORT levels preceded serum leptin rise. Overall, these results show that in FF rats, gene expression of hypothalamic appetite stimulating peptides first rise and then fall to nadir during the lights-on phase when leptin levels are in low range; adipocyte leptin mRNA rises before impending ingestive behavior and increased leptin secretion reaching peak manifests itself during nocturnal feeding. The FR regimen, which curtailed the normal body weight gain, abolished these daily fluctuations in gene expression of hypothalamic orexigenic peptides and adipocyte leptin but permitted feeding-associated increased leptin secretion. Thus, it may be important to consider the daily patterns of gene expression and availability of hypothalamic orexigenic peptides in investigations aimed at elucidating the central mechanisms underlying the feedback action of the normal and altered leptin secretion patterns.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THERE HAS BEEN a recent upsurge in investigations to understand the neuroendocrine control of energy homeostasis primarily due to the discovery of several hypothalamic neuropeptides that either stimulate or inhibit feeding when injected into the cerebral ventricles or directly into various hypothalamic sites (1, 2, 3). The neuropeptides that stimulate feeding and have been investigated extensively include neuropeptide Y (NPY), galanin (GAL), and the opioids, ß-endorphin (ß-END) and dynorphin (1, 2, 3, 4, 5, 6, 7, 8). Several investigations imply that NPY, produced primarily in the arcuate nucleus (ARC) of the hypothalamus, plays a physiological role in stimulating feeding in the rat during the dark phase of the light-dark cycle (9, 10, 11, 12, 13). Also, in several experimental paradigms with increased energy demands, such as fasting (11, 14) and diabetes (15, 16, 17, 18), NPY gene expression and release are up-regulated suggesting a tight relationship between NPY neurosecretion and hyperphagia. There is evidence that gene expression of POMC, the precursor protein for ß-END and {alpha}-MSH ({alpha}MSH), and gene expression of GAL in the ARC and other sites in the basal hypothalamus, also vary in accordance with changes in energy balance (2, 19, 20). Several attempts have been made to analyze the daily changes in gene expression and peptide levels of each of these orexigenic peptides in the hypothalamus (21, 22, 23, 24); however, the precise temporal relationship between their daily patterns and nocturnal feeding in rats maintained on a standard light-dark cycle and ad libitum food intake is not known.

Attempts to analyze the anatomical relationships among orexigenic signals in the hypothalamus document interconnections among neurons producing NPY, GAL, and ß-END. NPY-producing neurons in the ARC synapse with GAL and ß-END containing soma and dendrites and GAL-producing neurons were shown to be synaptically linked with ß-END immunopositive soma and dendrites in the ARC (25, 26, 27). That these anatomical links may be functionally relevant was suggested by the demonstrations that both NPY and GAL-induced feeding were partially suppressed by the opioid-receptor antagonist, nalaxone (28, 29), and that NPY stimulated the release of ß-END and GAL in the hypothalamus (26, 29, 30). Because of this communication among the three orexigenic neuropeptides, we tested the hypothesis that a daily pattern of fluctuations in their gene expression in the medial basal hypothalamus (MBH), which contains NPY, POMC, and GAL-producing neurons (31, 32, 33, 34), may manifest in relation to the robust feeding during the dark phase of the daily light-dark cycle.

Leptin, an adipocyte hormone, has recently been shown to inhibit food intake and is thought to play an important role in regulating the daily pattern of food intake in the rat (35, 36, 37, 38). Interestingly, morphological evidence suggests that the leptin receptor (leptin-R) is localized in hypothalamic neurons that produce NPY, GAL, and POMC (39, 40, 41, 42). Because leptin can modulate NPY gene expression and release (43), as well as GAL and POMC gene expression (40, 41, 44), the emerging view is that leptin restrains feeding, in part, by diminishing the output of these orexigenic signals and/or their actions at target sites (1, 2, 3). Further, whereas blood leptin levels and leptin gene expression in adipocytes show a daily pattern (45, 46, 47), the precise temporal relationship between these patterns and nocturnal feeding is not clear. Similarly, whereas coexpression of leptin-R (48) and NPY, GAL, and POMC in hypothalamic neurons is well documented (39, 40, 41, 42), little information is available on the nature of the dynamic changes in leptin-R gene expression, especially in relation to the daily pattern of leptin secretion. Consequently, in addition to the daily pattern of hypothalamic gene expression of the three neuropeptides, we have also analyzed gene expression of leptin-R in the MBH and leptin in adipocytes as well as blood leptin levels.

Previous studies showed that animals maintained on a food-restricted (FR) regimen (food availability for 4 h from 1100–1500 h) consume approximately 25–30% less and maintain a steady body weight in contrast to rats maintained on a free-feeding (FF) regimen with progressive weight gain (9, 49). In FR rats, NPY levels and release in the paraventricular nucleus (PVN), a site of leptin action (1, 2, 3, 9), are augmented in anticipation of food availability at 1100 h and then as the animals consume food both NPY content and release are diminished. NPY gene expression in the ARC is also augmented at 1100 h but unlike the content and release responses, it remained elevated regardless of food consumption (9, 49). We have extended these findings to evaluate the impact of similar FR on the daily pattern of gene expression of hypothalamic NPY, POMC, GAL, leptin-R, and adipocyte leptin and blood leptin levels.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Adult male SD rats (250–270 g), purchased from Zivic-Miller Laboratories, Inc. (Zelienople, PA), were housed individually in a light- and temperature-controlled room (lights on 0500–1900 h, 22 C). Food and water were available ad libitum during acclimatization. These studies were approved by the University of Florida Institutional Animal Care and Use Committee.

Rats were divided randomly into two groups: one group was allowed to feed freely (FF) and the other was food restricted (FR), with food available from 1100–1500 h for 4 weeks, as described earlier (49); water was available ad libitum to all rats. Body weights and 24-h food intake were recorded daily in an additional set of FF and FR rats (three rats/group). Groups of FF and FR rats were weighed and killed by decapitation at 4-h intervals through a 24-h period. The autopsy of the animals started 30 min before the designated hour, and all rats in the group were killed within 30 min. The brain was rapidly removed from each rat, and the medial basal hypothalamus was dissected and frozen on dry ice, then stored at -80 C until messenger RNA (mRNA) extraction. The hypothalamic tissue encompasses the neural tissue 1 mm lateral on both sides of midline extending rostral-caudally from optic chiasm to mamillary body recess. In general, the entire arcuate nucleus with minimal surrounding tissue was taken for analysis. Epididymal fat was similarly frozen. Serum from trunk blood was stored at -20 C until analysis of leptin and corticosterone (CORT). Leptin was measured using the rat leptin RIA kit (Linco Research, Inc., St. Charles, MO), and CORT levels were quantitiated by RIA with antiserum (B3–163) purchased from Endocrine Sciences, Inc. (Tarzana, CA). Levels of preproNPY, GAL, POMC, and leptin-R mRNA in the basal hypothalamus and leptin mRNA in epididymal fat were analyzed by ribonuclease protections assays (RPA; 49–55). This experiment was repeated three times to complete various analyses.

Riboprobes. Plasmid containing the rat NPY complementary DNA (cDNA) fragment was kindly provided by Dr. S. L. Sabol (NIH, Bethesda, MD). The pGem2-rat GAL plasmid containing a 585-bp cDNA fragment was generously provided by Dr. J. F. Hyde (University of Kentucky, Lexington, KY). Construction of the plasmid containing rat leptin cDNA has been described earlier (55).

To construct a rat leptin-R plasmid, a 21-mer upper primer (5'-TTG TAA GAG AGG CTG MYR ARA-3') and a 21-mer lower primer (5'-GAT TGG ATT GTG CTG GKT GAC-3') were designed based on mouse leptin-R gene sequence (GenBank Accession No. U42467; 48). RT-PCR of hypothalamic RNA was performed with these primers and the DNA fragment produced was sequenced and matched with the reported rat leptin-R gene sequence (5' position 907 to 3' position 1395, GenBank Accession No. U52966; 56). The leptin-R plasmid was ligated into pCRII vector (Invitrogen, Carlsbad, CA).

Similarly, the rat POMC plasmid was constructed with ligation of a 478-bp cDNA fragment (5' position 220, 3' position 697, GenBank Accession No. J00759; 57), into pGEM-T vector (Promega Corp., Madison, WI). The DNA fragment was prepared by RT-PCR, as described above, using a 20-mer upper (5'-CCC GAG AAA CAG CAG CAG TG-3') and a 20-mer lower (5'-AGG GGG CCT TGG AGT GAG AA-3') primer.

In vitro transcription templates were generated by linearizing with the restriction enzyme, SpeI, and 32P-labeled antisense riboprobes were synthesized using T7 RNA polymerase for use in RPAs.

Ribonuclease protection assays (RPA). Total RNA isolated from hypothalami with RNA-STAT-60 was divided into aliquots for estimation of various mRNAs by RPAs: NPY (6 µg), POMC (10 µg), leptin-R (20 µg), and GAL (20 µg) mRNA. Five micrograms of total RNA extracted from adipocyte tissue were used for analysis of leptin mRNA. A standardized protocol was used for various RPAs (49, 55). Briefly, the antisense probes and RNA samples were hybridized overnight at 45 C, followed by RNase A/T1 digestion for 1 h at 37 C. For GAL mRNA determination, S1 nuclease digestion was performed for 30 min at 37 C after overnight hybridization. Protected RNA fragments were isolated by ethanol precipitation and resolved on a 6% polyacrylamide denaturing sequencing gel. Each gel contained representative samples from each time point for the two groups of rats to account for gel loading variations. The dried gels were quantitated by a PhosphorImager analyzer (Molecular Dynamics, Inc., Sunnyvale, CA). The NPY, GAL, POMC, and leptin-R mRNA values were normalized to cyclophilin mRNA, and leptin mRNA was standardized relative to ß-actin. Antisense riboprobes for cyclophilin and ß-actin were synthesized using templates purchased from Ambion, Inc. (Austin, TX). Values are presented relative to these internal standards that were hybridized simultaneously with each sample.

Statistical analysis
Data are presented as mean ± SE. Daily body weight changes are presented as percent of initial body weight. Data for different time points within a group were compared by one-way ANOVA followed by Newman-Keul’s multiple comparison test and also analyzed using Bonferroni’s comparison test post hoc. Data for the same time point between the two groups were compared by Student’s t test. Level of significance was set at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effects of FR on body weight (Fig. 1Go)
As shown in Fig. 1Go, in one set of representative rats, FF rats steadily gained body weight (Fig. 1AGo) during the 4 weeks of observation. Food availability, restricted to 4 h from 1100–1500 h, initially resulted in loss of body weight during the first 2 days, thereafter, rats slowly regained their initial body weight by day 11 and then gained weight at a steady but slower rate than the FF rats. Their body weight at the end of 4 weeks was 27% below that of FF rats. The lower rate of body weight gain in FR rats can be attributed to a lower average daily food consumption of 23.4 ± 0.9 g compared with 35.2 ± 0.7 g for FF rats (P < 0.05). Similarly, the FR rats (n = 108) used for various analyses weighed 23% less than the FF rats (n = 76) at the termination of the experiment (FR:360 ± 3 g vs. FF:466 ± 3 g).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. A, Body weight change relative to the initial value in free feeding (FF) and feeding restricted (FR) rats. Availability of food was restricted to 4 h (1100–1500 h) in FR rats. B, Daily food intake of FF and FR rats (n = 3/group).

 
Daily fluctuations in hypothalamic neuropeptide gene expression: Effects of FR
NPY gene expression (Figs. 2Go and 3Go). In FF rats, hypothalamic NPY mRNA fluctuated with peak levels at 0700 h (P < 0.05); these elevated levels were sustained until 1100 h. A decrease in NPY gene expression to a significantly lower range occurred at 1500 h during the light phase, and interestingly, this low level was sustained throughout the dark phase. In FR rats, NPY gene expression did not vary during the 24-h period (Fig. 3Go). A comparison of FF and FR rats showed that the level of NPY gene expression was similar in the two groups at 0700 h and 1100 h (P > 0.05); however, the decrease thereafter, as seen in FF rats, was absent in FR rats.



View larger version (61K):
[in this window]
[in a new window]
 
Figure 2. The daily profiles in FF rats of dynamic changes in hypothalamic NPY mRNA, POMC mRNA, GAL mRNA, and leptin-R mRNA (data from 6–11 rats/time point) and in serum leptin (n = 6–7/time point), adipocyte leptin mRNA (n = 11–13) and hypothalamic leptin-R (BW = 465 ± 6.3; n = 4) shown on right panel. Dissimilar superscripts denote statistically significant differences (P < 0.05). Shaded bands represent the lights-off phase (1900–0500 h).

 


View larger version (59K):
[in this window]
[in a new window]
 
Figure 3. Daily profile in FR rats of dynamic changes in hypothalamic NPY mRNA, POMC mRNA, GAL mRNA, and leptin-R mRNA (n = 6/time point) shown on left panel and in serum leptin, adipocyte leptin. Food availability was restricted to the period 1100–1500 h; shaded bands represent the lights-off phase. Dissimilar superscripts denote statistically significant differences (P < 0.05).

 
GAL and POMC gene expression (Figs. 2Go and 3Go). As with NPY, a daily pattern was also evident in hypothalamic POMC and GAL mRNA in FF rats (Fig. 2Go; P < 0.05), which was abolished by FR (Fig. 3Go). However, there were two significant differences between the patterns of NPY and the GAL and POMC gene expression. First, the significant rise of GAL and POMC mRNAs occurred between 1100 and 1500 h, 4 h later than that in NPY mRNA (Fig. 2Go). Second, unlike NPY gene expression, in FR rats GAL and POMC gene expression were maintained in the range of the lowest levels found in FF rats (Fig. 3Go).

Daily fluctuations in serum CORT levels: effects of FR (Fig. 4Go)
Serum CORT levels in FF rats rose late in the evening at 1900 h, near the onset of dark phase and feeding; significantly high levels were also apparent later at 2300 h. Thereafter, during the later hours of dark phase and throughout the light phase levels were maintained at a basal level. Food availability restricted to 1100–1500 h shifted the daily rise in serum CORT levels. CORT levels rose at 1100 h, preceding the feeding phase, and returned to basal range at the end of the feeding at 1500 h.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 4. Daily profiles in FF and FR rats of dynamic changes in serum CORT levels (11–13 rats/time point). Dissimilar superscripts denote statistically significant differences (P < 0.05); shaded band represents the lights-off phase.

 
Daily fluctuations in serum leptin, adipocyte leptin mRNA, and hypothalamic leptin-R: effects of FR (Figs. 2Go and 3Go)
The temporal patterns of changes in serum leptin, adipocyte leptin mRNA levels, and hypothalamic leptin-R mRNA were markedly different from those of hypothalamic neuropeptide gene expression. As shown in Fig. 2Go, leptin mRNA remained unchanged during the lights-on phase (0700–1500 h levels) but increased significantly at the onset of lights-off phase (1900 h). These levels remained elevated throughout the lights-off phase and returned to the lower range of expression during the lights-on phase. In FR rats (Fig. 3Go), there were no significant fluctuations in leptin gene expression during the lights-on and lights-off phases of the light-dark cycle. A small increase evident at 1100 h and 1500 h was statistically not significant.

The pattern of serum leptin levels during the 24-h period in FF rats was somewhat different from that of adipocyte mRNA pattern (Fig. 2Go). Serum leptin concentrations rose during the dark phase to peak at 2300 h followed by a slow decrease to the low range maintained during the lights-on phase. It is apparent that serum leptin levels were low at 1900 h at the onset of the lights-off phase but increased to peak levels 4 h later at 2300 h. Thus, adipocyte mRNA increased significantly before, whereas serum leptin levels increased after initiation of feeding during the lights-off period. In FR rats, serum leptin levels were in the low range until 1100 h, the time of availability of rat chow (Fig. 3Go). Thereafter, during the 4 h of intense feeding leptin levels rose to a peak at 1500 h and then declined gradually to the basal range.

Hypothalamic leptin-R mRNA levels also varied during the 24-h period in FF rats with significantly higher levels at 1900 h when adipocyte leptin mRNA also rose (Fig. 2Go). Thereafter, a steady diminution in leptin-R mRNA to nadir at 0700 h was observed. In FR rats, however, hypothalamic leptin-R expression displayed no significant changes during the 24-h period (Fig. 3Go).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
When food is available ad libitum, a majority of the intake occurs during the dark phase of the light-dark cycle (58) and feeding begins after onset of the dark phase (1900 h in our laboratory). A large body of recent evidence suggests that this protracted dark-phase feeding is evoked by the release of one or more orexigenic signals that include NPY, GAL, and opioids such as ß-END (1, 2, 18, 29). Each of these peptidergic signals is synthesized and released locally at hypothalamic sites implicated in the control of feeding (1, 2, 6, 29). On the other hand, leptin is an adipocyte signal involved in regulating daily intake through modulation of the release and action of orexigenic peptides (2, 3, 35, 36, 37, 38, 39, 40, 41, 42). Because leptin secretion is reported to increase during the robust dark-phase feeding, it is assumed that this hypersecretion may, in part, play a role in maintenance of energy homeostasis through moderation of food intake (45, 46, 47). Several new findings have emerged when hypothalamic gene expression of NPY, GAL, and POMC were analyzed on a 24-h basis and correlated with dynamic shifts in leptin production and secretion in these animals. First, NPY, and GAL gene expression showed a daily rhythmic pattern with higher levels during the light-phase and POMC gene expression was lowest at 0700 h but rose significantly at 1100 and 1500 h each in conjunction with low serum leptin levels and with little, if any, feeding behavior. To the best of our knowledge, the current studies report for the first time a daily rhythm in hypothalamic GAL gene expression. By employing in situ hybridization for POMC in an area limited to the anterior 25% of the ARC, Steiner et al. (24) observed a peak in gene expression at 0600 h and lowest levels at 1800 h at the lights-off period. Akabayashi et al. (23) reported a diurnal rhythm in hypothalamic NPY mRNA with high levels from 1400–1600 h and a decrease, thereafter, in rats maintained on 12-h light, 12-h dark cycle with lights off from 1800–0600 h. Thus, there is a general consensus on the existence of daily patterns in neuropeptide gene expression. The discrepancies in the timing of peak levels in NPY and POMC gene expression may be related to differences in the light/dark cycle, housing of the animals and the procedures for analyzing peptide gene expression either by sensitive RPAs or semiquantitative in situ hybridization. Clearly, a study of temporal flux patterns of the fluctuations in neuropeptide levels and their release in feeding relevant site(s) in relation to daily changes in gene expression of these three neuropeptides is warranted. This information may shed light on our observation of abrupt rise and fall in neuropeptide gene expression preceding onset of night-time feeding behavior.

Second, an examination of the temporal relationships in peptide gene expression showed that increments in NPY gene expression occurred 4 h earlier than in GAL and POMC mRNA in our study. Several possible explanations can be advanced. It is likely that the gene expression of each of these neuropeptides is regulated by three independent mechanisms or that the daily pattern in NPY gene expression is regulated by mechanisms independently from that which regulate the GAL and POMC gene expression simultaneously. The increase in NPY gene expression manifesting 4 h before GAL and POMC is suggestive of the NPY system driving the expression of the other two. Morphological evidence that NPY neurons are synaptically linked with GAL and POMC producing neurons in the ARC (25, 26, 27) and stimulation of GAL and ß-END efflux by NPY are consistent with this possibility (28, 29, 30). However, additional studies are warranted to unequivocally demonstrate this putative NPYergic regulation of gene expression in GAL and POMC neurons in the hypothalamus.

Third, serum leptin levels remained low when hypothalamic gene expression of neuropeptides first increased and then decreased to low ranges. Leptin-R mRNA has been localized in NPY, GAL, and POMC producing neurons and administration of leptin modulates gene expression of these neuropeptides (39, 40, 41, 42, 43, 44). Further, diminution in serum leptin levels, as those produced by fasting (46, 52), resulted in up-regulation of NPY gene expression and conversely, administration of leptin suppressed the fasting-induced increase in hypothalamic NPY gene expression (52, 59). Daily administration of leptin intraventricularly decreased GAL and POMC mRNA in the hypothalamus (44). On the other hand, Schwartz et al. (60) reported increases in POMC mRNA in the rostral division of the arcuate nucleus by leptin treatment of fasted male rats. Also, leptin administration restored POMC gene expression in ob/ob mice to the range in wild-type controls (41). These lines of evidence imply that NPY, GAL, and POMC producing neurons are target sites of leptin action (39, 40, 41, 42, 43, 44). Although temporal periodicities do not strictly reflect causal relationships, our observation of both increases and decreases in hypothalamic neuropeptide gene expression in the presence of low leptin levels advocates reassessment of the physiological significance of circulating leptin. In fact, the temporal profiles of circulating leptin levels and fluctuations in neuropeptide gene expression are suggestive of an independent regulatory mechanism controlling the daily periodicities. Furthermore, from the FR study it is evident that shifting food availability to the lights-on phase abolished the daily patterns in neuropeptide gene expression but leptin hypersecretion after initiation of food consumption, was unaffected and, as seen in rats maintained on ad libitum food, peak serum levels occurred 4 h after initiation of feeding in these rats. Consequently, the physiological relevance of the well-known effects of exogenous leptin on neuropeptide gene expression remains to be clarified.

Fourth, a temporal dichotomy in the daily rise in adipocyte leptin gene expression and leptin secretion was evident in FF rats. Leptin gene expression rose at 1900 h, at the onset of nighttime feeding but before the rise in serum leptin levels. Saladin et al. (45) also reported a daily rhythm in leptin mRNA in adipose tissue of mice, with lowest gene expression during the entire lights-on phase, and enhanced gene expression at 4 h (2000 h) into the dark phase (lights on 0400–1600 h) followed by a peak at 0400 h. The leptin secretion pattern lagged behind the pattern in leptin gene expression, with serum leptin attaining nadir 2 h into the dark phase followed by a slow rise to peak at 0400 h. It is apparent that temporal differences in daily periodicities in leptin gene expression and circulating levels exist in rats and mice maintained on different light-dark cycles, but it is obvious that leptin gene expression precedes leptin secretion and, at least in rats, leptin gene expression is augmented before the impending ingestive activity. In contrast, increases in the rate of leptin secretion, as evident both in FF and FR rats, followed feeding behavior, an observation complementing that of Ahima et al. (47). Our observation of the rise in leptin gene expression before release implies that some unidentified neural and/or hormonal mechanisms may augment gene expression independently from those that elicit leptin secretion. The possibility that feeding-induced depletion in rat gastric epithelium may contribute toward the rise in serum leptin has recently been raised (61).

In this context, it is noteworthy that the temporal patterns of gene expression of adipocyte leptin and hypothalamic leptin-R were quite similar in terms of low levels during the lights-on phase and abrupt increase at the onset of ingestive behavior. However, whereas leptin-R gene expression decreased steadily thereafter, leptin gene expression remained elevated throughout the dark phase and decreased only during the lights-on phase. The causal factors responsible for this short-lived increase in hypothalamic leptin-R gene expression concomitant with adipocyte leptin gene expression remains to be ascertained.

Fifth, these results also demonstrated that changing the time of food availability to a 4-h period and limiting it to about 25% below the FF daily intake during this period, produced profound effects on hypothalamic neuropeptide and adipocyte gene expression and leptin secretion. A major finding is that FR abolished the daily patterns of fluctuations in gene expression of all three neuropeptides. Levels of gene expression were maintained either in the high range (NPY) or low range (GAL and POMC). In an earlier study (49), rats maintained on a similar FR regimen exhibited elevated NPY gene expression when examined during the lights-on phase. Thus, the current study extends these findings to show that despite an unchanged light-dark cycle, gene expression of orexigenic peptides is profoundly affected by FR and shift in time of food availability limited to the lights-on period. Whether shifting the FR regimen to other times during the light/dark cycle will produce similar impact is under investigation. The current results indicate that ad libitum food availability may be necessary to generate the daily patterns in gene expression of hypothalamic orexigenic peptides and adipocyte leptin but not leptin secretion.

As reported previously (62, 63), increase in serum CORT levels reflecting augmented hypothalamo-pituitary-adrenal activity, shifted with the time of food availability. Interestingly, serum CORT levels rose at the onset of feeding and decreased to a basal range at the end of 4 h of feeding, thereby affirming a tight relationship with the onset of daily corticosterone hypersecretion and onset of feeding behavior (62). Extending these studies, an analysis of the temporal relationship between CORT and leptin secretion and leptin adipocyte gene expression demonstrate that peak in serum CORT and adipocyte leptin gene expression coincide in FF rats and this coincidence was not apparent in FR rats due to absence of a daily pattern in adipocyte leptin gene expression. However, in FF and FR rats, the serum CORT levels rose before the rise in serum leptin levels. The physiological relevance of the contemporaneous rise in serum CORT and adipocyte leptin gene expression in FF rats, on one hand, and lag period between the rise in serum CORT and leptin levels, on the other, remains to be ascertained.

Finally, with respect to leptin biology, these studies showed also that FR eliminates the daily rise in adipocyte leptin and hypothalamic leptin-R gene expression. In contrast, increased leptin secretion during the period of feeding was unaffected by FR. Clearly, this association with feeding behavior of leptin secretion in FF and FR rats implies that the trigger for increased secretion is closely tied to ingestive behavior, a finding corroborating several reports in rodents (2, 45, 46, 47).

In conclusion, these findings reveal the occurrence of daily increases and decreases in hypothalamic gene expression of orexigenic neuropeptides in conjunction with low circulating leptin levels during the lights-on phase when rats display little feeding. A dichotomy in the daily rise in adipocyte leptin and hypothalamic leptin-R gene expression and serum leptin concentration was also evident, thereby suggesting disparate mechanisms regulating these daily responses. Whereas food availability restricted to 4 h during the lights-on phase abolished the daily pattern of gene expression of hypothalamic orexigenic peptides and leptin-R and adipocyte leptin, leptin secretion was found to be linked to feeding behavior. Thus, for elucidation of mechanisms underlying hypothalamic integration of energy balance under normal and altered conditions of food availability, it may be important to consider the daily patterns of gene expression and availability of hypothalamic orexigenic peptides and their relationship to adipocyte leptin feedback signaling.


    Acknowledgments
 
Thanks are due to Mrs. Dawn Stewart for editorial assistance.


    Footnotes
 
1 Supported by grants from the National Institutes of Health (DK-37273). Back

Received September 16, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kalra SP 1997 Appetite and body weight regulation: Is it all in the brain? Neuron 19:227–230[CrossRef][Medline]
  2. Kalra SP, Xu B, Dube MG, Pu S, Horvath TL, Kalra PS 1999 Interacting appetite regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68–100[Abstract/Free Full Text]
  3. Woods SC, Seeley RJ, Porte Jr D, Schwartz MW 1998 Signals that regulate food intake and energy homeostasis. Science 280:1378–1383[Abstract/Free Full Text]
  4. Clark JT, Kalra PS, Crowley WR, Kalra SP 1984 Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427–429[Abstract]
  5. Kyrkouli SE, Stanley BG, Leibowitz SF 1986 Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol 122:159–160[CrossRef][Medline]
  6. Leibowitz SF 1995 Brain peptides and obesity: pharmacologic treatments. Obes Res 3:573–589[Medline]
  7. Grandison L, Guidotti A 1977 Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 16:533–536[CrossRef][Medline]
  8. Levine AS, Billington CJ 1989 Opioids: are they regulators of feeding? Ann NY Acad Sci 575:209–219[Medline]
  9. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS 1991 Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88:10931–10935[Abstract/Free Full Text]
  10. Dube MG, Sahu A, Kalra PS, Kalra SP 1992 Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 131:684–688[Abstract]
  11. Sahu A, Kalra PS, Kalra SP 1988 Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9:83–86[CrossRef][Medline]
  12. Kalra SP, Kalra PS 1996 Is neuropeptide Y a naturally occurring appetite transducer? Curr Opin Endocrinol Diabetes 3:157–163
  13. Dube MG, Xu B, Crowley WR, Kalra PS, and Kalra SP 1994 Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 646:341–344[CrossRef][Medline]
  14. White JD, Kershaw M 1990 Increased hypothalamic neuropeptide Y expression following food deprivation. Mol Cell Neurosci 1:41–48
  15. Sahu A, Sninsky CA, Kalra PS, Kalra SP 1990 Neuropeptide Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192–198[Abstract]
  16. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS, Kalra SP 1992 Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 131:2979–2985[Abstract]
  17. White JD, Olchovsky D, Kershaw M, Berelowitz M 1990 Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126:765–772[Abstract]
  18. Williams G, Steel JH, Cardoso H, Ghatei MA, Lee YC, Gill JS, Burrin JM, Polak JM, Bloom SR 1988 Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 37:763–772[Abstract]
  19. Brady LS, Smith MA, Gold PW, Herkenham M 1990 Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52:441–447[Medline]
  20. Schwartz MW, Sipols AJ, Grubin CE, Baskin DG 1993 Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase. Brain Res Bull 31:361–367[CrossRef][Medline]
  21. Akabayashi A, Zaia CT, Koenig JI, Gabriel SM, Silva I, Leibowitz SF 1994 Diurnal rhythm of galanin-like immunoreactivity in the paraventricular and suprachiasmatic nuclei and other hypothalamic areas. Peptides 15:1437–1444[CrossRef][Medline]
  22. Akabayashi A, Watanabe Y, Gabriel SM, Chae HJ, Leibowitz SF 1994 Hypothalamic galanin-like immunoreactivity and its gene expression in relation to circulating corticosterone. Brain Res Mol Brain Res 25:305–312[Medline]
  23. Akabayashi A, Levin N, Paez X, Alexander JT, Leibowitz SF 1994 Hypothalamic neuropeptide Y and its gene expression: relation to light/dark cycle and circulating corticosterone. Mol Cell Neurosci 5:210–218[CrossRef][Medline]
  24. Steiner RA, Kabigting E, Lent K, Clifton DK 1994 Diurnal rhythm in proopiomelanocortin mRNA in the arcuate nucleus of the male rat. J Neuroendocrinol 6:603–608[CrossRef][Medline]
  25. Horvath TL, Naftolin F, Leranth C, Sahu A, Kalra SP 1996 Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 137:3069–3078[Abstract]
  26. Horvath TL, Naftolin F, Kalra SP, Leranth C 1992 Neuropeptide-Y innervation of ß-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis [published erratum appears in Endocrinology 1996 Feb;137(2):532]. Endocrinology 131:2461–2467[Abstract]
  27. Horvath TL, Kalra SP, Naftolin F, Leranth C 1995 Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J Neuroendocrinol 7:579–588[CrossRef][Medline]
  28. Morely JE 1987 Neuropeptide regulation of appetite and weight. Endocr Rev 8:256–287[Medline]
  29. Dube MG, Horvath TL, Leranth C, Kalra PS, Kalra SP 1994 Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav 56:811–813[CrossRef][Medline]
  30. Kalra PS, Norlin M, Kalra SP 1995 Neuropeptide Y stimulates beta-endorphin release in the basal hypothalamus: role of gonadal steroids. Brain Res 705:353–356[CrossRef][Medline]
  31. Everitt BJ, Hokfelt T 1989 The coexistence of neuropeptide Y with other peptides and amines in the central nervous system. In: Mutt V, Fuxe K, Hokfelt T, Lundberb J Neuropetide Y.Raven Press, New York, pp 61–72
  32. Chronwall BB 1990 Anatomical distribution of NPY and NPY messenger RNA in the brain. In: Mutt V, Füxe K, Hökfelt T, Lundberg JD (eds) Neuropeptide Y. Raven Press, New York, pp 51–60
  33. Khachaturian H, Lewis ME, Shafer MKH, Watson SJ 1985 Anatomy of CNS opioid system. Trends Neurosci 8:111–119[CrossRef]
  34. Merchenthaler I, Lopez FJ, Negro VA 1993 Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol 40:711–769[CrossRef][Medline]
  35. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Freidman J 1994 Positional cloning of the mouse obese gene and it human homologue. Nature 372:425–432[CrossRef][Medline]
  36. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight reducing effects of the plasma protein encoded by the obese gene. Science 269:543–546[Abstract/Free Full Text]
  37. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546–549[Abstract/Free Full Text]
  38. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540–543[Abstract/Free Full Text]
  39. Mercer JG, Haggard N, William LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P 1996 Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8:733–735[CrossRef][Medline]
  40. Cheung CC, Clifton DK, Steiner RA 1997 Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489–4492[Abstract/Free Full Text]
  41. Thornton JE, Cheung CC, Clifton DK, Steiner RA 1997 Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138:5063–5066[Abstract/Free Full Text]
  42. Håkansson ML, Brown H, Ghilardi N, Skoda RC, Meister B 1998 Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18:559–572[Abstract/Free Full Text]
  43. Stephens TW, Basincki M, Bristow PK, Bye-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffman J, Hsiung HM, Kriauciunas A, Mackellar W, Rosteck Jr PR, Schnener B, Smith D, Tinsley FC, Zhang X-Y, Herman M 1995 The role of neuropeptide Y in the anti-obesity action of the obese gene product. Nature 377:530–532[CrossRef][Medline]
  44. Sahu A 1998 Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 139:795–798[Abstract/Free Full Text]
  45. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527–529[CrossRef][Medline]
  46. Ahima RS, Prabakaran D, Mantroros C, Qu D, Lowell B, Maratos FE, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250–252[CrossRef][Medline]
  47. Ahima RS, Prabakaran D, Flier J 1998 Postnatal leptin surge and regulation of circadian rhythm by feeding: implication for energy homeostasis and neuroendocrine function. J Clin Invest 101:1020–1027[Medline]
  48. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271[CrossRef][Medline]
  49. Sahu A, White JD, Kalra PS, and Kalra SP 1992 Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. Brain Res Mol Brain Res 15:15–18[Medline]
  50. Kalra PS, Dube MG, Xu B, Farmerie WG, Kalra SP 1998 Neuropeptide Y (NPY) Y1 receptor mRNA is up-regulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance. J Neuroendocrinol 10:43–49[CrossRef][Medline]
  51. Kalra PS, Dube MG, Xu B, Kalra SP 1997 Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Regul Pept 72:121–130[CrossRef][Medline]
  52. Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Kalra SP 1998 Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Endocrinology 139:466–473[Abstract/Free Full Text]
  53. Xu B, Sahu A, Kalra PS, Crowley WR, Kalra SP 1996 Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides. Endocrinology 137:78–84[Abstract]
  54. Kalra PS, Pu S, Edwards T, Dube MG 1998 Hypothalamic galanin is upregulated during hyperphagia. Ann NY Acad Sci 863:432–435[Free Full Text]
  55. Kalra PS, Dube MG, Xu B, Farmerie WG, Kalra SP 1998 Evidence that dark-phase hyperphagia induced by neurotoxin 6-hydrodopamine may be due to decreased leptin and increased neuropeptide Y signaling. Physiol Behav 63:829–835[CrossRef][Medline]
  56. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CT, Hess JF 1996 Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18–19[CrossRef][Medline]
  57. Drouin J, Goodman HM 1980 Most of the coding region of rat ACTH-BLPH precursor gene lacks intervening sequences. Nature 288:610–613[CrossRef][Medline]
  58. Armstrong S 1980 A chronometric approach to the study of feeding behavior. Neurosci Behav Rev 4:27–53[CrossRef][Medline]
  59. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Lasser G, Prunkard DE, Porte Jr DJ, Woods SC, Seeley RJ, Weigle DS 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531–535[Abstract]
  60. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Camfiels A, Burn P, Baskin DG 1997 Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119–2123[Abstract]
  61. Bado A, Levasseur S, Attoub S, Kermorgant S, Laignen J-P, Bortoluzzi M-N, Molzo L, Lehy T, Guerro-Millo M, Marchand-Brustel YL, Lewin NJM 1998 The stomach is a source of leptin. Nature 394:790–793[CrossRef][Medline]
  62. Honma K-I, Honma S, Hiroshige T 1983 Critical role of food amount for prefeeding cortiocosterone peak in rats. Am J Physiol 245:R339–R344
  63. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, and Smith M 1993 Feast and Famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14:303–347[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Remmers, L. A. W. Verhagen, R. A. H. Adan, and H. A. Delemarre-van de Waal
Hypothalamic Neuropeptide Expression of Juvenile and Middle-Aged Rats after Early Postnatal Food Restriction
Endocrinology, July 1, 2008; 149(7): 3617 - 3625.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Ellis, K. M. Moar, T. J. Logie, A. W. Ross, P. J. Morgan, and J. G. Mercer
Diurnal profiles of hypothalamic energy balance gene expression with photoperiod manipulation in the Siberian hamster, Phodopus sungorus
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1148 - R1153.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. M. Kamiji and A. Inui
Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity
Endocr. Rev., October 1, 2007; 28(6): 664 - 684.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Lin, E.-J. D. Lin, D. Boey, N. J. Lee, K. Slack, M. J. During, A. Sainsbury, and H. Herzog
Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways
Endocrinology, May 1, 2007; 148(5): 2056 - 2065.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Zizzari, R. Longchamps, J. Epelbaum, and M. T. Bluet-Pajot
Obestatin Partially Affects Ghrelin Stimulation of Food Intake and Growth Hormone Secretion in Rodents
Endocrinology, April 1, 2007; 148(4): 1648 - 1653.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Goto, H. Arima, M. Watanabe, M. Hayashi, R. Banno, I. Sato, H. Nagasaki, and Y. Oiso
Ghrelin Increases Neuropeptide Y and Agouti-Related Peptide Gene Expression in the Arcuate Nucleus in Rat Hypothalamic Organotypic Cultures
Endocrinology, November 1, 2006; 147(11): 5102 - 5109.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. Komatsu, T. Chiba, H. Yamaza, K. To, H. Toyama, Y. Higami, and I. Shimokawa
Effect of leptin on hypothalamic gene expression in calorie-restricted rats.
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 890 - 898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Drazen, M. D. Wortman, R. J. Seeley, and S. C. Woods
Neuropeptide Y prepares rats for scheduled feeding
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1606 - R1611.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. P. Kalra, N. Ueno, and P. S. Kalra
Stimulation of Appetite by Ghrelin Is Regulated by Leptin Restraint: Peripheral and Central Sites of Action
J. Nutr., May 1, 2005; 135(5): 1331 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. I. C. Alonso-Vale, S. Andreotti, S. B. Peres, G. F. Anhe, C. das Neves Borges-Silva, J. C. Neto, and F. B. Lima
Melatonin enhances leptin expression by rat adipocytes in the presence of insulin
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E805 - E812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Bodosi, J. Gardi, I. Hajdu, E. Szentirmai, F. Obal Jr., and J. M. Krueger
Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1071 - R1079.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. M. Kong, N. M. Martin, K. L. Smith, J. V. Gardiner, I. P. Connoley, D. A. Stephens, W. S. Dhillo, M. A. Ghatei, C. J. Small, and S. R. Bloom
Triiodothyronine Stimulates Food Intake via the Hypothalamic Ventromedial Nucleus Independent of Changes in Energy Expenditure
Endocrinology, November 1, 2004; 145(11): 5252 - 5258.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R G P Denis, C Bing, S Brocklehurst, J A Harrold, R G Vernon, and G Williams
Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake
J. Endocrinol., October 1, 2004; 183(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Ueno, M. G. Dube, A. Inui, P. S. Kalra, and S. P. Kalra
Leptin Modulates Orexigenic Effects of Ghrelin and Attenuates Adiponectin and Insulin Levels and Selectively the Dark-Phase Feeding as Revealed by Central Leptin Gene Therapy
Endocrinology, September 1, 2004; 145(9): 4176 - 4184.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Vicentic, G. Dominguez, R. G. Hunter, K. Philpot, M. Wilson, and M. J. Kuhar
Cocaine- and Amphetamine-Regulated Transcript Peptide Levels in Blood Exhibit a Diurnal Rhythm: Regulation by Glucocorticoids
Endocrinology, September 1, 2004; 145(9): 4119 - 4124.
[Abstract] [F